Nandrolone Phenylpropionate 150 mg/mL (commonly branded as Deca P by Aquila Pharmaceuticals) is a fast-acting 19-nortestosterone ester widely used as an analytical reference standard in steroid testing and pharmaceutical research. Unlike the longer decanoate ester, the phenylpropionate chain provides a shorter half-life, making it ideal for studies involving rapid clearance and metabolite profiling. Supplied at ≥99.5% purity with complete HPLC, GC-MS, and NMR verification, this material is intended exclusively for licensed institutional use in method validation, forensic comparison, and quality-control applications.

• Appearance: Clear, colorless to pale-yellow oily solution
• Concentration: 150 mg/mL nandrolone phenylpropionate
• Molecular Formula: C27H34O3
• Molecular Weight: 406.56 g/mol

Nandrolone Phenylpropionate 150 mg/mL (Aquila Pharmaceuticals Deca P) — Clinical & Pharmaceutical Reference Guide

Introduction

Nandrolone Phenylpropionate (NPP) 150 mg/mL under the Aquila Pharmaceuticals Deca P label represents one of the most recognized fast-acting 19-nor anabolic-androgenic steroid presentations in both historical pharmaceutical and contemporary forensic contexts. The shorter phenylpropionate ester results in a significantly reduced detection window compared to nandrolone decanoate, making authentic reference material indispensable for anti-doping laboratories, law-enforcement forensics, and academic researchers studying rapid-onset 19-nor compounds. This pharmaceutical-grade analytical standard ensures traceability and reproducibility in every regulated analytical workflow.

Key Features & Scientific Relevance

• Purity ≥99.5% verified by third-party ISO/IEC 17025 laboratories
• Exact replication of Aquila Pharmaceuticals Deca P 150 mg/mL composition
• Preferred reference for short-ester nandrolone screening and confirmation methods
• Complete spectroscopic and chromatographic data package included
• Supplied only to institutions possessing valid controlled-substance registration

This clinical profile of Nandrolone Phenylpropionate 150 mg Aquila Pharmaceuticals provides an authoritative resource for professional analytical environments.

Product Specifications

• Active Ingredient: Nandrolone Phenylpropionate (17β-hydroxyestr-4-en-3-one 17-(3-phenylpropionate))
• Strength: 150 mg/mL
• Typical Vehicle: Benzyl benzoate, benzyl alcohol, miglyol 840 or grapeseed oil
• CAS Number: 62-90-8
• Molecular Formula: C27H34O3
• Molecular Weight: 406.56 g/mol
• Structural Classification: 19-Nor anabolic-androgenic steroid; short-to-medium chain phenylpropionate ester
• Appearance: Clear to slightly yellow viscous solution

These specifications faithfully reproduce the original Aquila Pharmaceuticals manufacturing profile.

Applications & Usage

Licensed facilities utilize this reference standard for:

• Validation of LC-MS/MS and GC-MS methods targeting short-ester nandrolone and 19-norandrosterone
• Forensic identification of seized fast-acting injectable preparations
• Pharmacokinetic and ester hydrolysis studies in vitro
• Development of rapid-screening immunoassays
• Comparative stability testing between short- and long-acting nandrolone esters

All use must occur under approved controlled-substance protocols.

Purity & Analytical Testing

Each batch undergoes comprehensive third-party analysis including:

• High-Performance Liquid Chromatography (HPLC) with UV/PDA detection
• Gas Chromatography-Mass Spectrometry (GC-MS)
• Nuclear Magnetic Resonance (1H-NMR, 13C-NMR)
• Fourier-Transform Infrared Spectroscopy (FTIR)
• Residual solvent and elemental impurity screening

Certificate of Analysis confirms ≥99.5% purity and absence of free nandrolone or phenylpropionic acid.

Safety & Handling Guidelines

Nandrolone Phenylpropionate is a Schedule III controlled substance (US) and equivalently regulated internationally. Handle under fume hood with nitrile gloves, safety goggles, and lab coat. Store at 15–30 °C, protected from light, in a locked, access-restricted cabinet. Disposal must comply with hazardous-waste and controlled-substance destruction regulations.

Secure & Confidential Distribution for Institutions

Material is released exclusively to verified license holders in plain, unmarked, tamper-evident packaging compliant with IATA dangerous-goods requirements. No external labeling indicates contents. Analytical documentation is delivered via secure encrypted portal with mandatory chain-of-custody documentation.

Why Choose This Reference Material?

• Precise match to Aquila Pharmaceuticals Deca P 150 mg/mL specification
• Full analytical data set (chromatograms, NMR, MS spectra, CoA)
• Trusted by WADA laboratories and forensic toxicology units worldwide
• Meets ISO/IEC 17025 and GMP reference-standard requirements

Legal & Safety Disclaimer

Nandrolone Phenylpropionate 150 mg/mL (Aquila Pharmaceuticals Deca P) reference standard is supplied strictly for analytical, forensic, research, and educational purposes within licensed facilities. It is not for human or veterinary use, not for resale as a medicinal product, and not available to individuals. Possession requires appropriate controlled-substance authorization. All applicable laws must be strictly followed.

FAQ Section

What is Deca P 150 mg Aquila Pharmaceuticals?

Deca P is a historical brand name for Nandrolone Phenylpropionate 150 mg/mL manufactured by Aquila Pharmaceuticals, distinguished by its fast-acting phenylpropionate ester.

Is Nandrolone Phenylpropionate regulated?

Yes, it is classified as a Schedule III controlled substance in the United States and is strictly regulated worldwide.

How is pharmaceutical-grade purity verified?

Purity is confirmed by accredited laboratories using HPLC, GC-MS, NMR, and FTIR; full results are provided in the Certificate of Analysis.

How should this reference standard be stored?

Store at controlled room temperature (15–30 °C), protected from light, in a secure, access-restricted location compliant with controlled-substance regulations.

Who is authorized to handle nandrolone phenylpropionate reference material?

Only personnel at institutions holding valid controlled-substance licenses (DEA, Home Office, or international equivalent) may possess or use this analytical standard.